EconomyHong Kong-listed Metis TechBio and Eli Lilly sign drug-delivery deal worth up to $1.1 billion

Hong Kong-listed Metis TechBio said Monday it has signed a collaboration agreement with Eli Lilly to research and develop tissue-specific drug-delivery technologies, in a deal valued at up to $1.1 billion.

business dealdrug deliverybiotechnology

RReuters★★☆☆☆2026-10-19 11:40Original